|
|
|
|
|
|
by chimeracoder
683 days ago
|
|
|
>
A significant portion of the cost is the drug trials. Excedrin Extra Strength and Excedrin Migraine have identical formulations, but IIRC Bayer spent $300m on FDA approval for migraine treatment, which is why the migraine variant continues to be more expensive. Your analogy would only be relevant if the US government paid $300M for the FDA approval and Bayer got to pocket 100% of the markup. |
|
|